Skip to main content

Home > Releases > Quarterly Financial Report > Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues (QFR101385USNO)

Q1 2026: 187,934
Updated: Jun 8, 2026 9:25 AM CDT
Q1 2026:  187,934  
Q4 2025:  199,768  
Q3 2025:  192,104  
Q2 2025:  180,963  
Q1 2025:  170,362  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

Fullscreen

Notes

Title Release Dates

2017-09-06 2026-06-08
 
Source    

2017-09-06 2026-06-08
 
Release    

2017-09-06 2026-06-08
 
Units    

2017-09-06 2026-06-08
 
Frequency    

2017-09-06 2026-06-08
 
Seasonal Adjustment    

2017-09-06 2026-06-08
 
Notes    

2017-09-06 2026-06-08